Capital Fund Management (CFM)’s Amicus Therapeutics FOLD Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.37M | Buy |
762,698
+450,137
| +144% | +$2.58M | 0.01% | 430 |
|
|
2025
Q1 | $2.55M | Buy |
312,561
+251,134
| +409% | +$2.05M | 0.01% | 506 |
|
|
2024
Q4 | $579K | Sell |
61,427
-25,344
| -29% | -$239K | ﹤0.01% | 714 |
|
|
2024
Q3 | $927K | Buy |
+86,771
| New | +$927K | ﹤0.01% | 605 |
|
|
2024
Q2 | – | Sell |
-69,431
| Closed | -$818K | – | 801 |
|
|
2024
Q1 | $818K | Buy |
+69,431
| New | +$818K | ﹤0.01% | 594 |
|
|
2023
Q2 | – | Sell |
-47,072
| Closed | -$522K | – | 731 |
|
|
2023
Q1 | $522K | Buy |
47,072
+8,250
| +21% | +$91.5K | ﹤0.01% | 501 |
|
|
2022
Q4 | $474K | Buy |
+38,822
| New | +$474K | ﹤0.01% | 488 |
|
|
2021
Q2 | – | Sell |
-24,864
| Closed | -$246K | – | 695 |
|
|
2021
Q1 | $246K | Buy |
+24,864
| New | +$246K | ﹤0.01% | 512 |
|
|
2020
Q3 | – | Sell |
-14,337
| Closed | -$216K | – | 687 |
|
|
2020
Q2 | $216K | Buy |
+14,337
| New | +$216K | ﹤0.01% | 489 |
|